NIFFENEGGER KATHI
SEC CIK 1620146 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EDSA | Edesa Biotech, Inc. | CFO | 10.7K | — | — | 1 | 2022-11-02 | 2022-11-02 |
Most active insiders at EDSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nijhawan Pardeep | CEO, Dir, 10% | $229.9K | — |
| 2 | Brooks Michael J | Pres | $3,140 | — |
| 3 | Weiler Peter J. | CFO | — | — |
| 4 | Liu Da David | Dir | — | — |
| 5 | Chypyha Joan | Dir | — | — |
| 6 | Marshall Patrick | Dir | — | — |
| 7 | MacDonald Sean Arthur | Dir | — | — |
| 8 | Sistilli Carlo | Dir | — | — |
| 9 | Olson Charles V | Dir | — | — |
NIFFENEGGER KATHI made no open-market trades at EDSA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-11-04 | 2022-11-02 | EDSA | Edesa Biotech, Inc. | NIFFENEGGER KATHI | CFO | A - Grant | $1.13 | +8,888 | 10.7K | +486% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations